| References |
1. Chen B, Xu M, Zhang H, Xu MZ, Wang XJ, Tang QH, Tang JY. The Antipancreatic Cancer Activity of OSI-027, a Potent and Selective Inhibitor of mTORC1 and mTORC2. DNA Cell Biol. 2015 Oct;34(10):610-7. doi: 10.1089/dna.2015.2886. Epub 2015 Aug 18. PubMed PMID: 26284306; PubMed Central PMCID: PMC4593879. 2. Cassir N, Delarozière JC, Dubourg G, Delord M, Lagier JC, Brouqui P, Fenollar F, Raoult D, Fournier PE. A Regional Outbreak of Clostridium difficile PCR-Ribotype 027 Infections in Southeastern France from a Single Long-Term Care Facility. Infect Control Hosp Epidemiol. 2016 Nov;37(11):1337-1341. Epub 2016 Aug 3. PubMed PMID: 27484769. 3. Mentula S, Laakso S, Lyytikäinen O, Kirveskari J. Differentiating virulent 027 and non-027 Clostridium difficile strains by molecular methods. Expert Rev Mol Diagn. 2015;15(9):1225-9. doi: 10.1586/14737159.2015.1069710. Epub 2015 Aug 4. PubMed PMID: 26289601. 4. Kamboj M, Xiao K, Kaltsas A, Huang YT, Sun J, Chung D, Wu S, Sheahan A, Sepkowitz K, Jakubowski AA, Papanicolaou G. Clostridium difficile infection after allogeneic hematopoietic stem cell transplant: strain diversity and outcomes associated with NAP1/027. Biol Blood Marrow Transplant. 2014 Oct;20(10):1626-33. doi: 10.1016/j.bbmt.2014.06.025. Epub 2014 Jun 25. PubMed PMID: 24973628; PubMed Central PMCID: PMC4852556. |
